<DOC>
	<DOC>NCT00251199</DOC>
	<brief_summary>VX-950 is an investigational drug , which is being tested in combination with a known treatment for hepatitis C, peginterferon.</brief_summary>
	<brief_title>VX-950 and Peginterferon for Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>infected with Hepatitis C virus contraindications to peginterferon therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>